Periodontal surgery. Diseases of oral cavity, salivary glands and jaws
Conditions
Interventions
Intervention 1: Patients will receive a Novafen capsules (containing 325 mg of acetaminophen, 200 mg ibuprofen and 40 mg caffeine) immediately before periodontal surgery. All drugs are manufactured by
Treatment - Drugs
Placebo
Patients will receive a Novafen capsules (containing 325 mg of acetaminophen, 200 mg ibuprofen and 40 mg caffeine) immediately before periodontal surgery. All drugs are manufactured by Alhavy pharmace
Patients wiil receive a Placebo (containing Starch) immediately before periodontal surgery. All drugs are manufactured by Alhavy pharmaceutical company (Tehran, Iran) in blinded label packages. All of
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:A consent to inclusion; In the age range 16 to 40 years; Patients candidate for crown lengthening surgery. Exclusion criteria: Systemic disease or mental; Addiction to alcohol or any mind-altering substance; Known sensitivity to NSAID, acetaminophen or caffeine.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: 1,2 and 3 days after Intervention. Method of measurement: Based on verbal rating scale.;Pain severity. Timepoint: 30 minutes,1 and 3 hours after Intervention. Method of measurement: Based on visual analgesic scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtabak Kashefimehr
Tabriz University of Medical Sciences
Outcome results
None listed